division of risk management: overview of review activities and rems - pharmacovigilance 2020
Published 4 years ago • 3.6K plays • Length 41:06Download video MP4
Download video MP3
Similar videos
-
38:16
considerations for rems surveys and assessments: planning and reporting - pharmacovigilance 2020
-
37:41
rems integration initiatives - pharmacovigilance 2020
-
42:22
development of shared system rems & implications of the appropriations act - pharmacovigilance 2020
-
30:38
keynote – pharmacovigilance and risk management conference 2020
-
57:37
risk evaluation and mitigation strategies (rems) compliance program
-
56:41
postmarket safety surveillance: tools, methods, and benefit-risk framework - pharmacovigilance 2020
-
35:16
overview of postmarketing drug safety reporting requirements - redi 2020
-
5:52
questions and discussion – pharmacovigilance 2020
-
54:27
fda's sentinel initiative - pharmacovigilance 2020
-
48:21
fda adverse event reporting system (faers) overview - pharmacovigilance 2020
-
48:50
advancing transparency and regulatory science activities on risk evaluation and mitigation strategy
-
4:19
rems (february 2015)
-
2:46
rems@fda tutorial (june 2016)
-
32:42
risk evaluation and mitigation strategies (rems) inspections (2of3) - jun. 19, 2018
-
29:50
#𝐑𝐌𝐏 #𝐑𝐢𝐬𝐤𝐌𝐚𝐧𝐚𝐠𝐞𝐦𝐞𝐧𝐭𝐩𝐥𝐚𝐧 #𝐑𝐄𝐌𝐒 #𝐏𝐕 #𝐀𝐠𝐠𝐫𝐞𝐠𝐚𝐭𝐞𝐫𝐞𝐩𝐨𝐫𝐭𝐬 - 𝐇𝐨𝐰 𝐭𝐨 𝐰𝐫𝐢𝐭𝐞 𝐚 𝐑𝐢𝐬𝐤 𝐦𝐚𝐧𝐚𝐠𝐞𝐦𝐞𝐧𝐭 𝐩𝐥𝐚𝐧 (𝐑𝐌𝐏)?
-
24:25
application of risk management principles for medical devices
-
0:46
#𝐬𝐡𝐨𝐫𝐭𝐬 #𝐑𝐌𝐏 #𝐑𝐄𝐌𝐒 #𝐏𝐡𝐚𝐫𝐦𝐚𝐜𝐨𝐯𝐢𝐠𝐢𝐥𝐚𝐧𝐜𝐞 𝐀𝐥𝐥 𝐚𝐛𝐨𝐮𝐭 𝐑𝐢𝐬𝐤 𝐦𝐚𝐧𝐚𝐠𝐞𝐦𝐞𝐧𝐭 𝐩𝐥𝐚𝐧 (𝐑𝐌𝐏) 𝐢𝐧 𝟏 𝐦𝐢𝐧𝐮𝐭𝐞
-
1:31:22
rems integration initiative: an overview – dec. 4, 2017
-
22:45
process for reviewing nonproprietary name suffix for biological products – pharmacovigilance 2020